1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018

The isothermal nucleic acid amplification technology (INAAT) market is poised to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. Though PCR technology dominates the nucleic acid amplification technology market currently, adoption of INAAT technology is expected to be significant in coming years as it offers better clinical results in detecting pathogens during point-of-care testing.

Amongst different products, reagent segment is expected to grow at a faster growth due to its increasing demand in reliable, specific and faster detection of chronic diseases and genetic disorders. On the other hand, infectious disease was found to be the highest revenue generating application segment of isothermal nucleic acid amplification technology (INAAT) market in 2013; it is also expected to grow at higher CAGR of 14.4% during the forecast period due to increasing prevalence of various infectious diseases such as HIV and hepatitis A & B and increasing adoption of INAAT in advanced detection of pathogens globally. Amongst different end-users, adoption of INAAT technologies in reference laboratories is expected to be significant due to increasing importance of advanced technologies in different complex molecular testing.

North America commanded the largest market share of about 44% in 2013; whereas, Asian INAAT market is expected to witness the highest CAGR. High prevalence rate of infectious diseases and significant adoption of novel technologies are the major driving factors in the Asian INAAT market. Leading players in the global INAAT market are also expected to address the unmet needs in emerging nations such as India, China, South Africa, Singapore, and Middle East among others.

The grey area, while estimating the market size, includes the overlapping nature of the applications. The application segment included infectious diseases, blood screening, genetics, oncology, research. It was difficult to evaluate the appropriate applications of INAAT; these were later clarified with the help of various experts that participated during the study. Technology market is not estimated as these are proprietary technologies of leading companies. However, qualitative information such as technology evolution, value chain analysis, comparative analysis of various proprietary technologies, and technology roadmap are incorporated in the research study.

The notable players in the global isothermal nucleic acid amplification technology market include Alere, Inc. (U.S.), Becton, Dickinson & Company (U.S.), BioHelix (U.S.), bioMerieux (France), Hologic Gene-Probe (U.S.), and QIAGEN (The Netherlands).

The extensive market study covers a detailed coverage of market momentum, an in-depth analysis of various influencing factors as well as a comprehensive snapshot of competitive landscape. Such all-inclusive research would help market players to identify growth potential of different sub-segments and formulate a suitable strategy to enter various related industries with the best portfolio.

Table Of Contents

Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018
Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Report Scope
1.3 Research Methodology
1.4 Key Data From Secondary and Primary Sources

2 Executive Summary

3 Technology Landscape Analysis
3.1 Technology Overview
3.2 INAAT Vs. Conventional Methods - Competitive Advantages
3.3 Technology Value Chain Analysis
3.4 Technology Capability and Maturity
3.5 Test Results General Nat Vs. INAAT Poct
3.6 Comparative Analysis Of INAAT Types

4 Technology Investment Potential
4.1 Investment Climate Assessment
4.1.1 Investor Network
4.1.1.1 Investment Climate Assessment
4.1.1.2 Philanthropic Bodies
4.1.1.3 Private Investors and Venture Capital Firms
4.1.1.4 Insights on Current and Future Technology Investment Trends
4.1.1.5 Some Of The Funds and Investments on INAAT
4.2 Evaluation Of Technologies Available For Licensing and Acquisition For Stakeholders
4.3 Analysis Of Potential Application Areas For Technology Investment Using Ose Grid
4.3.1 Ose - Parameters For Evaluation

5 Market Landscape Analysis
5.1 Market Segmentation
5.2 Market Share in Molecular Diagnostics (Mdx)
5.3 Market Dynamics
5.3.1 Drivers - Description
5.3.2 Restraints - Description
5.3.3 Challenges - Description
5.4 Demand-Side Analysis

6 Product Market
6.1 Product/Technology Innovations - Applications
6.1.1 Product/Technology Innovations - Applications
6.1.1.1 INAAT Instrument Market - By Geography
6.1.1.2 INAAT Reagent Market - By Geography

7 Applications Market
7.1 INAAT and Molecular Diagnostics
7.2 Infectious Disease Diagnostics
7.3 Blood Screening
7.4 Laboratory Research
7.5 Cancer Research
7.6 Global INAAT Market - By Application (2013-2018)
7.6.1 INAAT Infectious Diseases Market, By Geography
7.6.2 INAAT Blood Screening Market - By Geography
7.6.3 INAAT Research Market - By Geography

8 End-User Market
8.1 Global Isothermal Nucleic Acid Amplification Technology Market - By End User (2013-2018)
8.2 Global Market - By End User
8.2.1 INAAT Hospitals Market - By Geography
8.2.2 INAAT Reference Laboratories Market - By Geography
8.2.3 INAAT Other End-Users Market - By Geography
8.3 INAAT Market For Hospitals, By Application
8.4 INAAT Market For Reference Laboratories, By Application
8.5 INAAT Market For Other End Users, By Application

9 Geographic Analysis
9.1 Technology Adoption and Development - Key Findings
9.1.1 Global Isothermal Nucleic Acid Amplification Technology Market - By Geography (2013-2018)
9.2 North America
9.2.1 North America - INAAT Market, By Application
9.2.2 North America - Market, By Product
9.2.3 North America - Market, By End User
9.3 Europe
9.3.1 Europe - INAAT Market, By Application
9.3.2 Europe - Market, By Product
9.3.3 Europe - Market, By End User
9.4 Asia
9.4.1 Asia - INAAT Market, By Application
9.4.2 Asia - Market, By Product
9.4.3 Asia - Market, By End User
9.5 Rest Of The World (ROW)
9.5.1 ROW- INAAT Market, By Application
9.5.2 ROW- Market, By Product
9.5.3 ROW- Market, By End User
9.6 Regions With High Technology Adoption

10 Competitive Landscape
10.1 Partnerships, Collaborations and Agreements
10.2 New Product Launches
10.3 Mergers and Acquisitions

11 Company Profiles
11.1 Alere
11.2 Becton, Dickinson and Company (Bd)
11.3 Biohelix
11.4 Biomerieux
11.5 Eiken Chemical Co., Ltd.
11.6 Hologic Gen-Probe
11.7 Lucigen
11.8 Meridian Bioscience, Inc.
11.9 New England Biolabs
11.10 Novartis Diagnostics
11.11 Nugen
11.12 Qiagen
11.13 Ustar Biotechnologies (Hangzhou) Ltd.


List of Tables


Table 1 NIH Funding Details and Estimation For Infectious Diseases During The Fiscal Year (Fy) 2010-2015
Table 2 Gates Foundation Grants ($) (2010-2014)
Table 3 Global Isothermal Nucleic Acid Amplification Technology Market, By Product, 2011-2018 ($Million)
Table 4 INAAT Instruments Market, By Geography, 2011-2018 ($Million)
Table 5 INAAT Reagents Market, By Geography, 2011-2018 ($Million)
Table 6 Global Isothermal Nucleic Acid Amplification Technology Market, By Application, 2011-2018 ($Million)
Table 7 INAAT Infectious Diseases Market, By Geography, 2011-2018 ($Million)
Table 8 INAAT Blood Screening Market, By Geography, 2011-2018 ($Million)
Table 9 INAAT Research Market, By Geography, 2011-2018 ($Million)
Table 10 Global Isothermal Nucleic Acid Amplification Technology Market, By End User, 2011-2018 ($Million)
Table 11 INAAT Hospitals Market, By Geography, 2011-2018 ($Million)
Table 12 INAAT Reference Laboratories Market, By Geography, 2011-2018 ($Million)
Table 13 INAAT Other End-Users Market, By Geography, 2011-2018 ($Million)
Table 14 INAAT Hospital Market Revenue, By Application, 2011-2018 ($Million)
Table 15 INAAT Reference Laboratories Market Revenue, By Application, 2011-2018 ($Million)
Table 16 INAAT Other End Users Market Revenue, By Application, 2011-2018 ($Million)
Table 17 North America: Market, By Application, 2011-2018 ($Million)
Table 18 North America: Market, By Product, 2011-2018 ($Million)
Table 19 North America: Market, By End User, 2011-2018 ($Million)
Table 20 Europe: Market, By Application, 2011-2018 ($Million)
Table 21 Europe: Market, By Product, 2011-2018 ($Million)
Table 22 Europe: Market, By End User, 2011-2018 ($Million)
Table 23 Asia: Market, By Application, 2011-2018 ($Million)
Table 24 Asia: Market, By Product, 2011-2018 ($Million)
Table 25 Asia: Market, By End User, 2011-2018 ($Million)
Table 26 ROW: Market, By Application, 2011-2018 ($Million)
Table 27 ROW: Market, By Product, 2011-2018 ($Million)
Table 28 ROW: Market, By End User, 2011-2018 ($Million)
Table 29 Partnerships, Collaborations and Agreements, 2011-2014
Table 30 New Product Launches, 2011-2014
Table 31 Mergers and Acquisitions, 2011-2014
List of Figures


Figure 1 Research Methodology
Figure 2 INAAT Vs. Molecular Diagnostics: Market Revenue Forecast, 2011-2018
Figure 3 Technology Evolution
Figure 4 INAAT Vs. Conventional Methods - Competitive Advantages
Figure 5 Technology Value Chain Analysis
Figure 6 INAAT Capability Towards Poct
Figure 7 Test Results General Nat Vs. INAAT Poct
Figure 8 Comparative Analysis Of INAAT Types
Figure 9 Technology Roadmap
Figure 10 Attractive Forces For Increased Market Value
Figure 11 Investor Network
Figure 12 NIH Funds Towards Infectious Diseases
Figure 13 Opportunity Strategic Evaluation Analysis
Figure 14 Market Segmentation
Figure 15 Market Share in Molecular Diagnostics (Mdx)
Figure 16 Market Dynamics
Figure 17 Drivers Impact - Timeline
Figure 18 Restraints Impact - Timeline
Figure 19 Current and Emerging Opportunities
Figure 20 Demand-Side Analysis
Figure 21 Market Share, By Product, 2013-2018
Figure 22 Global Market, By Product, 2013 and 2018 ($Million)
Figure 23 INAAT Instruments Market, By Geography, 2013 and 2018 ($Million)
Figure 24 Global INAAT Reagents Market, By Geography, 2013 and 2018 ($Million)
Figure 25 Isothermal Nucleic Acid Amplification Technology Applications Market
Figure 26 INAAT Products Currently Available For Infectious Diseases
Figure 27 Market Share, By Application, 2013-2018
Figure 28 Global Market, By Application, 2013 and 2018 ($Million)
Figure 29 INAAT Infectious Diseases Market, By Geography, 2013 and 2018 ($Million)
Figure 30 INAAT Blood Screening Market, By Geography, 2013 and 2018 ($Million)
Figure 31 INAAT Research Market, By Geography, 2013 and 2018 ($Million)
Figure 32 Market Share, By End User, 2013-2018
Figure 33 Global Market, By End-User, 2013 and 2018 ($Million)
Figure 34 INAAT Hospitals Market, By Geography, 2013 and 2018 ($Million)
Figure 35 INAAT Reference Laboratories Market, By Geography, 2013 and 2018 ($Million)
Figure 36 INAAT Other End-Users Market, By Geography, 2013 and 2018 ($Million)
Figure 37 INAAT Hospital Market Revenue, By Application, 2013 Vs. 2018, ($Million)
Figure 38 INAAT Reference Laboratories Market Revenue, By Application, 2013 Vs 2018 ($Million)
Figure 39 INAAT Others End Users Market Revenue, By Application, 2013 Vs. 2018 ($Million)
Figure 40 Market Share, By Geography, 2013-2018
Figure 41 North America: Market, By Application, 2013 Vs. 2018 ($Million)
Figure 42 North America: Market, By Product, 2013 Vs.2018 ($Million)
Figure 43 North America: Market, By End User, 2013 Vs. 2018 ($Million)
Figure 44 Europe: Market, By Application, 2013 Vs.2018 ($Million)
Figure 45 Europe: Market, By Product, 2013 Vs.2018 ($Million)
Figure 46 Europe: Market, By End User, 2013 Vs.2018 ($Million)
Figure 47 Asia: Market, By Application, 2013 Vs.2018 ($Million)
Figure 48 Asia: Market, By Product, 2013 Vs.2018 ($Million)
Figure 49 Asia: Market, By End User, 2013 Vs.2018 ($Million)
Figure 50 ROW: Market, By Application, 2013 Vs.2018 ($Million)
Figure 51 ROW: Market, By Product, 2013 Vs.2018 ($Million)
Figure 52 ROW: Market, By End User, 2013 Vs.2018 ($Million)
Figure 53 Key Growth Strategies Of The Global Isothermal Nucleic Acid Amplification Technologies Market, 2011-2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 52500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 75-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 35000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Asia-Pacific diagnostic testing market, including Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.